The FDA Has Approved An Obesity Drug That Helped Some People Drop Weight By 15% : NPR

In company-funded studies, participants taking the Novo Nordisk drug Wegovy had average weight loss of about 34 pounds. In a comparison group getting dummy shots, the average loss was under 6 pounds.

$1500 a month? Breakthrough obesity injection Wegovy (semaglutide) approved by the FDA — but high costs and limited insurance coverage likely to limit adoption - Genetic Literacy Project

Video FDA approves drug to treat obesity - ABC News

Mounjaro: Weight Loss Drug Suppresses Appetite, Awaits FDA Approval

New weight loss treatment is marked by heavy marketing and modest results

The FDA Has Approved An Obesity Drug That Helped Some, 42% OFF

Study identifies factors associated with long-term use of FDA-approved anti- obesity medications

F.D.A. Approves New Obesity Drug Tirzepatide That Will Compete With Wegovy - The New York Times

Pediatricians Recommend Weight-Loss Drugs for Obese Children - WSJ

An Overview of Anti-Obesity Medications

Nutrition, gutsandgrowth

Houseknecht Laboratory - Mood, Metabolism & Medicine